After 2.5 months from hospital admission, MPO activity remained elevated in both post-COVID-19 male (233.5 ± 118.2 U/L, n = 14) and female (203.1 ± 77.1 U/L, n = 7) patients. The gene discussed is MPO; the disease is COVID-19.